Altered Effector CD4+ T Cell Function in IL-21R−/− CD4+ T Cell-Mediated Graft-Versus-Host Disease

Abstract

We previously showed that transplantation with IL-21R gene-deficient splenocytes resulted in less severe graft-versus-host disease (GVHD) than was observed with wild type splenocytes. In this study, we sought to find mechanism(s) explaining this observation. Recipients of donor CD4+ T cells lacking IL-21R exhibited diminished GVHD symptoms, with reduced inflammatory cell infiltration into the liver and intestine, leading to prolonged survival. After transplantation, CD4+ T cell numbers in the spleen were reduced, and MLR and cytokine production by CD4+ T cells were impaired. These results suggest that IL-21 might promote GVHD through enhanced production of effector CD4+ T cells. Moreover, we found that CD25 depletion altered neither the impaired MLR in vitro nor the ameliorated GVHD symptoms in vivo. Thus, the attenuated GVHD might be caused by an impairment of effector T cell differentiation itself, rather than by an increase in regulatory T cells and suppression of effector T cells.